Medison Pharma Canada News Today : Breaking News, Live Updates & Top Stories | Vimarsana

IN BRIEF: Amryt, Medison sign distribution deal for Myalepta in Canada Tue, 9th Mar 2021 06:55 Amryt Pharma PLC - commercial-stage biopharmaceutical company - Signs a distribution agreement with Medison Pharma Canada to distribute Myalepta in Canada. This agreement completes the multi-regional distribution agreements with Medison, announced in February, to distribute Myalept and Lojuxta in Israel, and Juxtapid in Canada. Today s announcement represents continued progress as we grow our commercial assets and expand access to treatment for patients in existing and new territories. We are also pleased to extend our engagement with Medison and further benefit from their expertise in Canada and other territories, says Amryt Chief Executive Joe Wiley.

Joe wileyEvelina grecenkoAlliance newsAmryt pharmaMedison pharma canadaAmryt chief executive joeAll rightsஓஹோ விலேகூட்டணி செய்திஇடைநிலை பார்மா கனடாஅனைத்தும் உரிமைகள்